Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000266:Adenylyl Imidodiphosphate / Q000008:administration & dosage; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000201:enzymology*; D000242:Cyclic AMP / Q000008:administration & dosage / Q000378:metabolism; D005260:Female; D006160:Guanosine Triphosphate / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D008274:Magnesium / Q000008:administration & dosage; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology; D011458:Prostaglandins E / Q000494:pharmacology; D051381:Rats; D012075:Remission, Spontaneous; D012969:Sodium Fluoride / Q000008:administration & dosage
D011458:Prostaglandins E; D000266:Adenylyl Imidodiphosphate; D003994:Bucladesine; D006160:Guanosine Triphosphate; D012969:Sodium Fluoride; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D008274:Magnesium